AUCKLAND, New Zealand--(BUSINESS WIRE)--Mesynthes Ltd, a privately held regenerative medicine company, has been renamed Aroa Biosurgery Ltd (Aroa) to reflect its new strategic focus on soft tissue repair and reconstruction.
Brian Ward, Chief Executive Officer, says New Zealand-based Aroa is targeting the international biosurgery market with its Reinforced Bioscaffold portfolio for abdominal wall reconstructions, including complex hernia.
Help employers find you! Check out all the jobs and post your resume.
